{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:14:16Z","timestamp":1783707256186,"version":"3.55.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Hodgkin lymphoma (HL) is a highly curable B-cell lymphoma, but a group of patients may experience resistance to initial treatment or progress to refractory disease. Moreover, they may experience relapses or long-term complications such as infertility and secondary neoplasms. In this retrospective cohort study, 257 patients diagnosed with HL between 2002 and 2022 were included to identify clinical and laboratory predictors of survival that may contribute to managing patient treatment and follow-up strategies. Demographic, clinical, treatment, and laboratory data at diagnosis were collected from patients\u2019 e-records. Overall survival (OS) and progression-free survival (PFS) were analyzed using Kaplan\u2013Meier curves and log-rank tests. Univariable and multivariable Cox proportional hazards models were used to identify independent predictors of death. The median age at diagnosis was 29 years, with 54.9% males. Nodular sclerosis was the most common subtype (34.6%). Univariable Cox regression analysis showed that high creatinine levels (HR 7.55, 95% CI 2.62\u201321.81, p\u2009&lt;\u2009.001), low platelet count (HR 4.87, 95% CI 1.58\u201314.94, p\u2009=\u2009.006), and high total bilirubin (HR 3.76, 95% CI 1.34\u201310.55, p\u2009=\u2009.012) are factors associated with poor survival. In the exploratory multivariable Cox regression analysis, poor response to treatment was strongly associated with poor survival (HR 7.89, 95% CI 2.39\u201326.06, p=&lt;.001), followed by low platelet count (HR 4.72, 95% CI 1.28\u201317.46, p\u2009=\u20090.020). This may suggest that poor treatment response and low platelet count are independent predictors of poor survival in HL patients but require confirmation in a larger cohort. Early detection of high-risk patients based on these clinical and laboratory results may improve patient treatment and follow-up strategies.<\/jats:p>","DOI":"10.1371\/journal.pone.0353363","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:22:52Z","timestamp":1783704172000},"page":"e0353363","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and outcomes of Hodgkin Lymphoma: A single institution retrospective cohort study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9131-1555","authenticated-orcid":true,"given":"Anwar","family":"Rjoop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5066-6193","authenticated-orcid":true,"given":"Rania","family":"Al-Samama\u2019h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5661-0803","authenticated-orcid":true,"given":"Taima Sari","family":"Al-ullemat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8621-7623","authenticated-orcid":true,"given":"Rahaf","family":"Alshamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5434-6306","authenticated-orcid":true,"given":"Batool","family":"El-Dwakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roaa","family":"Al-Saidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0191-0895","authenticated-orcid":true,"given":"Noor","family":"Abdalhakem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7603-3712","authenticated-orcid":true,"given":"Saja","family":"Alsarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3734-4935","authenticated-orcid":true,"given":"Asmaa","family":"Ajarmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"11","key":"pone.0353363.ref001","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112647","article-title":"An update on the pathology and molecular features of Hodgkin lymphoma","volume":"14","author":"A Satou","year":"2022","journal-title":"Cancers"},{"issue":"17","key":"pone.0353363.ref002","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.3390\/cancers17172929","article-title":"Hodgkin Lymphoma Classification-From Historical Concepts to Current Refinements","volume":"17","author":"A Carbone","year":"2025","journal-title":"Cancers (Basel)"},{"key":"pone.0353363.ref003","doi-asserted-by":"crossref","unstructured":"Li W. The 5th edition of the World Health Organization classification of hematolymphoid tumors. 2022. 36395314","DOI":"10.36255\/exon-publications-leukemia-who-5th-edition-hematolymphoid-tumors"},{"issue":"4","key":"pone.0353363.ref004","doi-asserted-by":"crossref","first-page":"101514","DOI":"10.1016\/j.beha.2023.101514","article-title":"Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment","volume":"36","author":"R Masel","year":"2023","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1","key":"pone.0353363.ref005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-022-01281-9","article-title":"Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis","volume":"15","author":"J Huang","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"10","key":"pone.0353363.ref006","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.3324\/haematol.2024.285281","article-title":"Changes in sex-specific incidence of lymphoid neoplasms across the lifespan","volume":"109","author":"B Valcarcel","year":"2024","journal-title":"Haematologica"},{"key":"pone.0353363.ref007","unstructured":"Ma\u2019touq A, El Azhari M, Al Sarway J, Haron O. Cancer Incidence in Jordan - 2022. https:\/\/www.moh.gov.jo\/ebv4.0\/root_storage\/ar\/eb_list_page\/%D8%A7%D9%84%D8%AA%D9%82%D8%B1%D9%8A%D8%B1_%D8%A7%D9%84%D8%B3%D9%86%D9%88%D9%8A_%D9%84%D8%A7%D8%B5%D8%A7%D8%A8%D8%A7%D8%AA_%D8%A7%D9%84%D8%B3%D8%B1%D8%B7%D8%A7%D9%86_%D8%A7%D9%84%D9%85%D8%B3%D8%AC%D9%84%D8%A9_%D9%81%D9%8A_%D8%A7%D9%84%D8%A7%D8%B1%D8%AF%D9%86_%D9%84%D8%B9%D8%A7%D9%85_2022.pdf"},{"issue":"4","key":"pone.0353363.ref008","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.hemonc.2020.10.002","article-title":"The epidemiology of lymphoma in Jordan: A nationwide population study of 4189 cases according to World Health Organization classification system","volume":"14","author":"TN Aladily","year":"2021","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"46","key":"pone.0353363.ref009","article-title":"Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin\u2019s Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study","volume":"35","author":"JM Lee","year":"2020","journal-title":"J Korean Med Sci"},{"issue":"4","key":"pone.0353363.ref010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195629","article-title":"Overview and outcome of Hodgkin\u2019s Lymphoma: Experience of a single developing country\u2019s oncology centre","volume":"13","author":"RP Shamoon","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"pone.0353363.ref011","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41392-023-01600-7","article-title":"Long-term survival benefit of anti-PD-1 therapy in patients with relapsed or refractory classical Hodgkin lymphoma","volume":"8","author":"W Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"pone.0353363.ref012","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.seminhematol.2016.05.010","article-title":"Treatment of relapsed and refractory Hodgkin Lymphoma","volume":"53","author":"B von Tresckow","year":"2016","journal-title":"Semin Hematol"},{"issue":"2","key":"pone.0353363.ref013","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clml.2020.08.018","article-title":"Classical Hodgkin Lymphoma: Clinicopathologic Features, Prognostic Factors, and Outcomes From a 28-Year Single Institutional Experience","volume":"21","author":"A Rose","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"pone.0353363.ref014","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12185-016-2007-1","article-title":"Clinical features and outcomes of 139 Japanese patients with Hodgkin lymphoma","volume":"104","author":"S Makita","year":"2016","journal-title":"Int J Hematol"},{"issue":"3","key":"pone.0353363.ref015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000490489","article-title":"Bone Involvement in Hodgkin\u2019s Lymphoma: Clinical Features and Outcome","volume":"140","author":"F Gaudio","year":"2018","journal-title":"Acta Haematol"},{"issue":"6","key":"pone.0353363.ref016","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/bloodadvances.2024014689","article-title":"The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool","volume":"9","author":"MJ Maurer","year":"2025","journal-title":"Blood Adv"},{"issue":"3","key":"pone.0353363.ref017","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00277-025-06292-3","article-title":"The validation of advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in Turkish patients with classical Hodgkin lymphoma","volume":"104","author":"O Koca","year":"2025","journal-title":"Ann Hematol"},{"issue":"3","key":"pone.0353363.ref018","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.seminhematol.2016.05.004","article-title":"Treatment of early-stage Hodgkin lymphoma","volume":"53","author":"A Engert","year":"2016","journal-title":"Semin Hematol"},{"issue":"3","key":"pone.0353363.ref019","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.seminhematol.2016.05.006","article-title":"Treatment of advanced-stage Hodgkin lymphoma","volume":"53","author":"TP Vassilakopoulos","year":"2016","journal-title":"Semin Hematol"},{"issue":"5","key":"pone.0353363.ref020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"BD Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"pone.0353363.ref021","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jclinepi.2022.08.016","article-title":"Handling missing data in clinical research","volume":"151","author":"MW Heymans","year":"2022","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"pone.0353363.ref022","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/j.seminhematol.2016.05.005","article-title":"Clinical presentation and staging of Hodgkin lymphoma","volume":"53","author":"A Gallamini","year":"2016","journal-title":"Semin Hematol"},{"issue":"11","key":"pone.0353363.ref023","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00247-019-04529-8","article-title":"Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma","volume":"49","author":"KM McCarten","year":"2019","journal-title":"Pediatr Radiol"},{"issue":"5","key":"pone.0353363.ref024","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/bjh.70115","article-title":"Refining the risk stratification in advanced-stage classical Hodgkin lymphoma: A critical analysis of clinical prediction models","volume":"207","author":"O Koca","year":"2025","journal-title":"Br J Haematol"},{"key":"pone.0353363.ref025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0040-1712842","article-title":"Predictors of poor response to salvage chemotherapy in relapsed\/ refractory pediatric Hodgkin lymphoma- a retrospective analysis from tertiary cancer centre in India","volume":"54","author":"S Bhethanabhotla","year":"2020","journal-title":"Ann Natl Acad Med Sci"},{"key":"pone.0353363.ref026","article-title":"Newly Diagnosed Classical Hodgkin Lymphoma: Optimizing Outcomes in a New Therapeutic Era","author":"AM Evens","year":"2025","journal-title":"Hematol Oncol"},{"key":"pone.0353363.ref027","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hon.3163_5","article-title":"Nivolumab (N)\u2010AVD improves progression\u2010free survival compared to brentuximab vedotin (BV)\u2010AVD in advanced stage (AS) classic Hodgkin lymphoma (HL): results of SWOG S1826","volume":"41","author":"AF Herrera","year":"2023","journal-title":"Hematol Oncol"},{"issue":"2","key":"pone.0353363.ref028","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.21.01281","article-title":"Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial","volume":"41","author":"L-M Fornecker","year":"2023","journal-title":"J Clin Oncol"},{"issue":"5","key":"pone.0353363.ref029","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","article-title":"PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations","volume":"15","author":"Y Jiang","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"pone.0353363.ref030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0039-3402429","article-title":"The Role of Platelets in Cancer-Related Bleeding Risk: A Systematic Review","volume":"46","author":"JB Larsen","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"9","key":"pone.0353363.ref031","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/s41416-024-02630-w","article-title":"Risk and adverse clinical outcomes of thrombocytopenia among patients with solid tumors-a Danish population-based cohort study","volume":"130","author":"K Adelborg","year":"2024","journal-title":"Br J Cancer"},{"issue":"3","key":"pone.0353363.ref032","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jha2.727","article-title":"Hemoglobin\u2010platelet index as a prognostic factor in patients with peripheral T\u2010cell lymphoma","volume":"4","author":"Y Yagi","year":"2023","journal-title":"EJHaem"},{"issue":"1","key":"pone.0353363.ref033","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.clml.2011.09.215","article-title":"Prognostic value of platelet count in diffuse large B-cell lymphoma","volume":"12","author":"L-P Chen","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"pone.0353363.ref034","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41408-023-00930-7","article-title":"Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models","volume":"13","author":"J Jelicic","year":"2023","journal-title":"Blood Cancer J"},{"key":"pone.0353363.ref035","article-title":"Thrombocytopenia in cancer patients","author":"HA Liebman","year":"2014","journal-title":"Thromb Res"},{"issue":"4","key":"pone.0353363.ref036","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3892\/etm.2016.3683","article-title":"Hypersplenism: History and current status","volume":"12","author":"Y Lv","year":"2016","journal-title":"Exp Ther Med"},{"issue":"1","key":"pone.0353363.ref037","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12959-024-00637-0","article-title":"Practical approach to thrombocytopenia in patients with sepsis: a narrative review","volume":"22","author":"K Satoh","year":"2024","journal-title":"Thromb J"},{"key":"pone.0353363.ref038","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-214669","article-title":"Thrombocytopenia and fever: not just another infection\u2026","volume":"2016","author":"P Sriskandarajah","year":"2016","journal-title":"BMJ Case Rep"},{"key":"pone.0353363.ref039","first-page":"41","article-title":"Renal infiltration presenting as acute kidney injury in Hodgkin lymphoma - A case report and review of the literature","volume":"10","author":"WFd Silva","year":"2018","journal-title":"Leuk Res Rep"},{"issue":"13","key":"pone.0353363.ref040","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3390\/cancers15133391","article-title":"Higher Plasma Creatinine Is Associated with an Increased Risk of Death in Patients with Non-Metastatic Rectal but Not Colon Cancer: Results from an International Cohort Consortium","volume":"15","author":"J Ose","year":"2023","journal-title":"Cancers (Basel)"},{"key":"pone.0353363.ref041","doi-asserted-by":"crossref","first-page":"710423","DOI":"10.3389\/fonc.2021.710423","article-title":"Association Between Serum Creatinine Concentrations and Overall Survival in Patients With Colorectal Cancer: A Multi-Center Cohort Study","volume":"11","author":"M Yang","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"pone.0353363.ref042","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4082\/kjfm.23.0116","article-title":"Low serum creatinine as well as high serum creatinine is associated with prognosis of patients with cancer in end-of-life","volume":"46","author":"YJ Lee","year":"2025","journal-title":"Korean J Fam Med"},{"issue":"20","key":"pone.0353363.ref043","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003728","article-title":"Renal Function and All-Cause Mortality Risk Among Cancer Patients","volume":"95","author":"Y Yang","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"pone.0353363.ref044","first-page":"1527","article-title":"Small increases in serum creatinine are associated with prolonged ICU stay and increased hospital mortality in critically ill patients with cancer","volume":"19","author":"J Samuels","year":"2011","journal-title":"Support Care Cancer"},{"key":"pone.0353363.ref045","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1182\/blood-2018-99-115897","article-title":"Impact of creatinine clearance in patients with diffuse large B-cell lymphoma treated with R-CHOP: a real-world long-term observation analysis at a single institute","volume":"132","author":"N Nishimura","year":"2018","journal-title":"Blood"},{"issue":"1","key":"pone.0353363.ref046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.46439\/nephrology.5.016","article-title":"Analysis of chronic kidney disease on diagnosis, treatment, prognosis and related risk factors in patients with lymphoma: A mini-review","volume":"5","author":"B Qin","year":"2025","journal-title":"J Exp Nephrol"},{"issue":"1","key":"pone.0353363.ref047","doi-asserted-by":"crossref","first-page":"2513106","DOI":"10.1080\/2162402X.2025.2513106","article-title":"The combination of body mass index and serum creatinine levels predicts survival in patients with Hodgkin lymphoma treated with nivolumab in the CheckMate 205 study","volume":"14","author":"R De Filippi","year":"2025","journal-title":"Oncoimmunology"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:22:59Z","timestamp":1783704179000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353363"}},"subtitle":[],"editor":[{"given":"Mehmet","family":"Baysal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0353363","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}